PB2109: REALMIND: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY OF PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA STARTING SECOND/THIRD-LINE THERAPY AND NOT RECE...

por Flowers, C. R., Burke, J. M., Vukcevic, M., Snodgrass, S., Saverno, K., Lumiqued, M. A. A.
Publicado 2022

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study

por de Vos, S, Swinnen, L J, Wang, D, Reid, E, Fowler, N, Cordero, J, Dunbar, M, Enschede, S H, Nolan, C, Petrich, A M, Ross, J A, Salem, A H, Verdugo, M, Agarwal, S, Zhou, L, Kozloff, M, Nastoupil, L J, Flowers, C R
Publicado 2018